March/April 2015

Biopharma Asia

March/April 2015 | Volume 4 Issue 2


Supplier Qualification for Single-Use Technology

By: Scott M. Wheelwright, Co Founder and Principal Consultant Complya Asia Co., Ltd


Low Endotoxin Recovery: An FDA Perspective

By: Patricia F. Hughes, Ph.D.,Team Leader in FDA/CDER in the Office of Pharmaceutical Qua...


Analysing the Analytical Techniques for Counterfeit Drug Detection

By: Anna Luczak, Ph.D., Scientist Ravi Kalyanaraman, Ph.D., Associate Director Bristol-...


Pharmaceutical Sourcing Strategies – An Indian perspective

By: Dr. Sanjit Singh Lamba, MPharm, PhD Managing Director, President-Global Brands Unit ...


Trends and Opportunities in Pediatric Drug Development

By: Daniel E. Schaufelberger, Ph.D., Scientific Director and CMC Leader Janssen Research...


The United States Pharmacopeia Addresses the Issue of Leachables and Extractables

By: Daniel Norwood, Distinguished Research Fellow Boehringer Ingelheim Pharmaceuticals, ...